手术出院后阿片类与非阿片类镇痛的系统综述与随机试验荟萃分析
该系统综述与荟萃分析检索1990年1月1日至2021年7月8日多个数据库,纳入47项多剂量随机对照试验共6607例患者,比较手术出院后阿片类与非阿片类镇痛。阿片类未降低出院后第1天疼痛强度(加权均数差0.01cm,95%CI -0.26至0.27;中等确定性),但增加呕吐风险(相对危险度4.50,95%CI 1.93至10.51;高确定性)及其他不良事件。
要点
- 手术出院后阿片类处方未降低第1天疼痛强度(加权均数差0.01cm,95%CI -0.26至0.27)。
- 阿片类增加呕吐风险(相对危险度4.50,95%CI 1.93至10.51;高确定性)。
- 证据主要来自小型和中型择期手术,作者认为这些手术场景可考虑非阿片类镇痛。
核心结论
- 荟萃分析结果支持手术出院后阿片类处方不降低疼痛强度但增加不良事件。
- 证据依赖小型和中型择期手术试验,作者认为临床医生在这些手术场景可考虑非阿片类镇痛。
- 数据主要来自低质量试验,且无涉及大型或大型复杂手术患者的试验,作者指出该领域亟需提升研究质量与范围。
研究设计与样本
- 系统综述与荟萃分析,检索MEDLINE、Embase、Cochrane Library、Scopus、AMED、Biosis和CINAHL从1990年1月1日至2021年7月8日。
- 纳入47项多剂量随机对照试验,共6607例患者,年龄15岁及以上,按生理与手术严重度评分定义(小型、中型、大型和大型复杂)出院后比较阿片类与非阿片类镇痛。
- 30项(64%)试验涉及择期小型手术(63%牙科手术),17项(36%)试验涉及中型手术(47%骨科和29%普通外科手术)。
- 采用随机效应荟萃分析,使用GRADING系统评估证据确定性,研究注册于PROSPERO(ID CRD42020153050)。
主要发现
- 与无阿片类镇痛相比,阿片类处方未降低出院后第1天疼痛(加权均数差0.01cm,95%CI -0.26至0.27;中等确定性),其他术后时间点也无降低(中等至极低确定性)。
- 阿片类处方与呕吐风险增加相关(相对危险度4.50,95%CI 1.93至10.51;高确定性),并与其他不良事件包括恶心、便秘、头晕和嗜睡相关(高至中等确定性)。
- 阿片类未影响其他结局。
临床怎么用
- 作者认为,在小型和中型择期手术场景,临床医生可考虑处方非阿片类镇痛。
局限性
- 证据依赖聚焦小型和中型择期手术的试验。
- 数据主要来自低质量试验。
- 无涉及大型或大型复杂手术患者的试验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Excessive opioid prescribing after surgery has contributed to the current opioid crisis; however, the value of prescribing opioids at surgical discharge remains uncertain. We aimed to estimate the extent to which opioid prescribing after discharge affects self-reported pain intensity and adverse events in comparison with an opioid-free analgesic regimen. METHODS: In this systematic review and meta-analysis, we searched MEDLINE, Embase, the Cochrane Library, Scopus, AMED, Biosis, and CINAHL from Jan 1, 1990, until July 8, 2021. We included multidose randomised controlled trials comparing opioid versus opioid-free analgesia in patients aged 15 years or older, discharged after undergoing a surgical procedure according to the Physiological and Operative Severity Score for the Enumeration of Mortality and Morbidity definition (minor, moderate, major, and major complex). We screened articles, extracted data, and assessed risk of bias (Cochrane's risk-of-bias tool for randomised trials) in duplicate. The primary outcomes of interest were self-reported pain intensity on day 1 after discharge (standardised to 0-10 cm visual analogue scale) and vomiting up to 30 days. Pain intensity at further timepoints, pain interference, other adverse events, risk of dissatisfaction, and health-care reutilisation were also assessed. We did random-effects meta-analyses and appraised evidence certainty using the Grading of Recommendations, Assessment, Development, and Evaluations scoring system. The review was registered with PROSPERO (ID CRD42020153050). FINDINGS: 47 trials (n=6607 patients) were included. 30 (64%) trials involved elective minor procedures (63% dental procedures) and 17 (36%) trials involved procedures of moderate extent (47% orthopaedic and 29% general surgery procedures). Compared with opioid-free analgesia, opioid prescribing did not reduce pain on the first day after discharge (weighted mean difference 0·01cm, 95% CI -0·26 to 0·27; moderate certainty) or at other postoperative timepoints (moderate-to-very-low certainty). Opioid prescribing was associated with increased risk of vomiting (relative risk 4·50, 95% CI 1·93 to 10·51; high certainty) and other adverse events, including nausea, constipation, dizziness, and drowsiness (high-to-moderate certainty). Opioids did not affect other outcomes. INTERPRETATION: Findings from this meta-analysis support that opioid prescribing at surgical discharge does not reduce pain intensity but does increase adverse events. Evidence relied on trials focused on elective surgeries of minor and moderate extent, suggesting that clinicians can consider prescribing opioid-free analgesia in these surgical settings. Data were largely derived from low-quality trials, and none involved patients having major or major-complex procedures. Given these limitations, there is a great need to advance the quality and scope of research in this field. FUNDING: The Canadian Institutes of Health Research.
引用
- Fiore JF, El-Kefraoui C, Chay MA, et al. Opioid versus opioid-free analgesia after surgical discharge: a systematic review and meta-analysis of randomised trials. Lancet. 2022. PMID: 35717988. doi:10.1016/S0140-6736(22)00582-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。